LeonaBio, Inc.
LONA
$7.04
-$0.98-12.22%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -4.43% | 82.76% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.26% | 73.17% | |||
| Operating Income | -6.26% | -73.17% | |||
| Income Before Tax | 42.31% | 60.25% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 42.31% | 60.25% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 42.31% | 60.25% | |||
| EBIT | -6.26% | -73.17% | |||
| EBITDA | -6.36% | -75.02% | |||
| EPS Basic | 53.74% | 88.83% | |||
| Normalized Basic EPS | 54.10% | 37.26% | |||
| EPS Diluted | 53.74% | 88.83% | |||
| Normalized Diluted EPS | 54.10% | 37.26% | |||
| Average Basic Shares Outstanding | 24.70% | 255.96% | |||
| Average Diluted Shares Outstanding | 24.70% | 255.96% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||